BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15958578)

  • 1. Inhibition of DNA repair by a herpes simplex virus vector enhances the radiosensitivity of human glioblastoma cells.
    Hadjipanayis CG; DeLuca NA
    Cancer Res; 2005 Jun; 65(12):5310-6. PubMed ID: 15958578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery.
    Hadjipanayis CG; Fellows-Mayle W; Deluca NA
    Mol Ther; 2008 Nov; 16(11):1783-8. PubMed ID: 18728637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0.
    Lees-Miller SP; Long MC; Kilvert MA; Lam V; Rice SA; Spencer CA
    J Virol; 1996 Nov; 70(11):7471-7. PubMed ID: 8892865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.
    Maachani UB; Kramp T; Hanson R; Zhao S; Celiku O; Shankavaram U; Colombo R; Caplen NJ; Camphausen K; Tandle A
    Mol Cancer Res; 2015 May; 13(5):852-62. PubMed ID: 25722303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma.
    Reichert S; Rödel C; Mirsch J; Harter PN; Tomicic MT; Mittelbronn M; Kaina B; Rödel F
    Radiother Oncol; 2011 Oct; 101(1):51-8. PubMed ID: 21852011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
    Härle P; Sainz B; Carr DJ; Halford WP
    Virology; 2002 Feb; 293(2):295-304. PubMed ID: 11886249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
    Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
    Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus gene products required for viral inhibition of expression of G1-phase functions.
    Song B; Yeh KC; Liu J; Knipe DM
    Virology; 2001 Nov; 290(2):320-8. PubMed ID: 11883196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICP0 gene expression is a herpes simplex virus type 1 apoptotic trigger.
    Sanfilippo CM; Blaho JA
    J Virol; 2006 Jul; 80(14):6810-21. PubMed ID: 16809287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation.
    Spear MA; Sun F; Eling DJ; Gilpin E; Kipps TJ; Chiocca EA; Bouvet M
    Cancer Gene Ther; 2000 Jul; 7(7):1051-9. PubMed ID: 10917208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7.
    Boutell C; Canning M; Orr A; Everett RD
    J Virol; 2005 Oct; 79(19):12342-54. PubMed ID: 16160161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.
    Thompson RL; Sawtell NM
    J Virol; 2006 Nov; 80(22):10919-30. PubMed ID: 16943285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for the nuclear-cytoplasmic translocation of infected-cell protein 0 of herpes simplex virus 1.
    Lopez P; Van Sant C; Roizman B
    J Virol; 2001 Apr; 75(8):3832-40. PubMed ID: 11264372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo protein.
    Cuchet D; Ferrera R; Lomonte P; Epstein AL
    J Gene Med; 2005 Sep; 7(9):1187-99. PubMed ID: 15852412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 1 regulatory protein ICP0 does not protect cyclins D1 and D3 from degradation during infection.
    Everett RD
    J Virol; 2004 Sep; 78(18):9599-604. PubMed ID: 15331692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation.
    Hausmann C; Temme A; Cordes N; Eke I
    Oncotarget; 2015 Oct; 6(33):34592-605. PubMed ID: 26460618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cyclin D3 in the biology of herpes simplex virus 1 ICPO.
    Van Sant C; Lopez P; Advani SJ; Roizman B
    J Virol; 2001 Feb; 75(4):1888-98. PubMed ID: 11160688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.
    Miller CS; Danaher RJ; Jacob RJ
    J Virol; 2006 Apr; 80(7):3360-8. PubMed ID: 16537603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICP27-dependent resistance of herpes simplex virus type 1 to leptomycin B is associated with enhanced nuclear localization of ICP4 and ICP0.
    Lengyel J; Strain AK; Perkins KD; Rice SA
    Virology; 2006 Sep; 352(2):368-79. PubMed ID: 16780914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner.
    Boutell C; Everett RD
    J Virol; 2004 Aug; 78(15):8068-77. PubMed ID: 15254178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.